Dose escalation study of the HLA-A2-WT1 CD3 bispecific antibody RO7283420 in relapsed/refractory acute myeloid leukemia

Martin Hutchings, Koorosh Korfi, Pau Montesinos, Armando Santoro, Hsin-An Hou, Pilar Martinez-Sanchez, Susana Vives, Sara Galimberti, Tsai-Yun Chen, Marco Frigeni, Sylvain Garciaz, Olga Salamero Garcia, Su-Peng Yeh, Karen Yee, Jordi Esteve, Ashish Bajel, Shaun Fleming, Anne Catherine Bretz, Jan Attig, Min Sun, Sina Nassiri, Tobias Rutishauser, Christian Klein, Y. May Ma, Gabriel Schnetzler, Stephanie Vauleon, Huixin Yu, Teresa Barata, Muriel Richard, Silke Simon, Heather Hinton, Nino Keshelava, Marion Subklewe

Open source

DOI: 10.1016/j.bneo.2025.100110
Published: 2025-08
Container: Blood Neoplasia
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.bneo.2025.100110,
  title = {Dose escalation study of the HLA-A2-WT1 CD3 bispecific antibody RO7283420 in relapsed/refractory acute myeloid leukemia},
  author = {Martin Hutchings and Koorosh Korfi and Pau Montesinos and Armando Santoro and Hsin-An Hou and Pilar Martinez-Sanchez and Susana Vives and Sara Galimberti and Tsai-Yun Chen and Marco Frigeni and Sylvain Garciaz and Olga Salamero Garcia and Su-Peng Yeh and Karen Yee and Jordi Esteve and Ashish Bajel and Shaun Fleming and Anne Catherine Bretz and Jan Attig and Min Sun and Sina Nassiri and Tobias Rutishauser and Christian Klein and Y. May Ma and Gabriel Schnetzler and Stephanie Vauleon and Huixin Yu and Teresa Barata and Muriel Richard and Silke Simon and Heather Hinton and Nino Keshelava and Marion Subklewe},
  year = {2025},
  journal = {Blood Neoplasia},
  doi = {10.1016/j.bneo.2025.100110},
  url = {https://doi.org/10.1016/j.bneo.2025.100110}
}

RIS

TY  - JOUR
TI  - Dose escalation study of the HLA-A2-WT1 CD3 bispecific antibody RO7283420 in relapsed/refractory acute myeloid leukemia
AU  - Martin Hutchings
AU  - Koorosh Korfi
AU  - Pau Montesinos
AU  - Armando Santoro
AU  - Hsin-An Hou
AU  - Pilar Martinez-Sanchez
AU  - Susana Vives
AU  - Sara Galimberti
AU  - Tsai-Yun Chen
AU  - Marco Frigeni
AU  - Sylvain Garciaz
AU  - Olga Salamero Garcia
AU  - Su-Peng Yeh
AU  - Karen Yee
AU  - Jordi Esteve
AU  - Ashish Bajel
AU  - Shaun Fleming
AU  - Anne Catherine Bretz
AU  - Jan Attig
AU  - Min Sun
AU  - Sina Nassiri
AU  - Tobias Rutishauser
AU  - Christian Klein
AU  - Y. May Ma
AU  - Gabriel Schnetzler
AU  - Stephanie Vauleon
AU  - Huixin Yu
AU  - Teresa Barata
AU  - Muriel Richard
AU  - Silke Simon
AU  - Heather Hinton
AU  - Nino Keshelava
AU  - Marion Subklewe
PY  - 2025
JO  - Blood Neoplasia
DO  - 10.1016/j.bneo.2025.100110
UR  - https://doi.org/10.1016/j.bneo.2025.100110
ER  -

APA

Hutchings, M., Korfi, K., Montesinos, P., Santoro, A., Hou, H., Martinez-Sanchez, P., Vives, S., Galimberti, S., Chen, T., Frigeni, M., Garciaz, S., Garcia, O. S., Yeh, S., Yee, K., Esteve, J., Bajel, A., Fleming, S., Bretz, A. C., Attig, J., Sun, M., Nassiri, S., Rutishauser, T., Klein, C., Ma, Y. M., Schnetzler, G., Vauleon, S., Yu, H., Barata, T., Richard, M., Simon, S., Hinton, H., Keshelava, N., & Subklewe, M. (2025). Dose escalation study of the HLA-A2-WT1 CD3 bispecific antibody RO7283420 in relapsed/refractory acute myeloid leukemia. Blood Neoplasia. https://doi.org/10.1016/j.bneo.2025.100110

Source records

crossref · retrieved 2026-09-25T13:50:54.513Z